Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,921 to 1,940 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance. | Thorac Cancer | 2020 | 31777195 | PubTator, text mining | PubMed |
| Multifaceted Roles of TIM-Family Proteins in Virus-Host Interactions. | Trends Microbiol | 2020 | 31732320 | PubTator, text mining | PubMed |
| A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. | Cell Mol Gastroenterol Hepatol | 2020 | 31689560 | PubTator, text mining | PubMed |
| Interleukin 10 promotes macrophage uptake of HDL and LDL by stimulating fluid-phase endocytosis. | Biochim Biophys Acta Mol Cell Biol Lipids | 2020 | 31676439 | PubTator, text mining | PubMed |
| TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting. | Cancer Immunol Immunother | 2020 | 31664482 | PubTator, text mining | PubMed |
| Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus. | Clin Rheumatol | 2020 | 31655933 | PubTator, text mining | PubMed |
| Target-Mediated Drug Disposition Pharmacokinetic/Pharmacodynamic Model-Informed Dose Selection for the First-in-Human Study of AVB-S6-500. | Clin Transl Sci | 2020 | 31599479 | PubTator, text mining | PubMed |
| Gamma-glutamyl-carboxylated Gas6 mediates positive role of vitamin K on lowering hyperglycemia in type 2 diabetes. | Ann N Y Acad Sci | 2020 | 31583710 | PubTator, text mining | PubMed |
| A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis. | Oncogene | 2020 | 31477837 | PubTator, text mining | PubMed |
| Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro. | J Thromb Haemost | 2020 | 31442368 | PubTator, text mining | PubMed |
| Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer. | Cell Biol Toxicol | 2020 | 31250347 | PubTator, text mining | PubMed |
| Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies. | Transl Cancer Res | 2019 | 35117021 | PubTator, text mining | PubMed |
| Blockade of AXL activation overcomes acquired resistance to EGFR tyrosine kinase inhibition in non-small cell lung cancer. | Transl Cancer Res | 2019 | 35116995 | PubTator, text mining | PubMed |
| A retrospective analysis of the correlation between AXL expression and clinical outcomes of patients with urothelial bladder carcinoma. | Transl Cancer Res | 2019 | 35116837 | PubTator, text mining | PubMed |
| The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein-protein interaction in glioblastoma. | Neurooncol Adv | 2019 | 32642659 | PubTator, text mining | PubMed |
| Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions. | JNCI Cancer Spectr | 2019 | 32337478 | PubTator, text mining | PubMed |
| Rational Drug Design of Axl Tyrosine Kinase Type I Inhibitors as Promising Candidates Against Cancer. | Front Chem | 2019 | 32117858 | PubTator, text mining | PubMed |
| Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities. | Front Microbiol | 2019 | 31998254 | PubTator, text mining | PubMed |
| Vitamin K and Bone Health: A Review on the Effects of Vitamin K Deficiency and Supplementation and the Effect of Non-Vitamin K Antagonist Oral Anticoagulants on Different Bone Parameters. | J Osteoporos | 2019 | 31976057 | PubTator, text mining | PubMed |
| Overcoming the Intrinsic Gefitinib-resistance via Downregulation of AXL in Non-small Cell Lung Cancer. | J Cancer Prev | 2019 | 31950021 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=97